使用机器学习模型预测患有炎症性肠道疾病的Medicare服务费受益人自我管理的生物不坚持
Christian Rhudy1, Courtney Perry2, Cody Bumgardner3
1University of Kentucky Healthcare, Pharmacy Services, Lexington.
Journal of managed care & specialty pharmacy
|December 24, 2025
概括
机器学习模型可以使用Medicare索赔数据预测炎症性肠病 (IBD) 患者的药物不坚持. 包装模型对改善治疗坚持的临床决策支持有希望.
科学领域:
- 生物医学信息学是生物医学信息学.
- 医疗服务研究 医疗服务研究
- 机器学习在医疗保健中的应用
背景情况:
- 在炎症性肠病 (IBD) 中不遵守生物疗法会导致疾病爆发和不良结果.
- 准确预测不遵守是及时干预的关键.
研究的目的:
- 开发机器学习模型,利用Medicare服务费索赔预测IBD患者的药物不服药情况.
- 评估各种机器学习模型的性能,以识别不粘附的生物疗法器件.
主要方法:
- 使用的医疗保险服务费索赔数据从2017-2021年用于IBD的受益人.
- 在受益者和发放水平上定义的不遵守,不包括不完整的数据或不够的生物发放.
- 训练和评估了16个机器学习模型,使用AUC,准确性,F1分数,P/NPV,灵敏度和特异性来评估性能.
主要成果:
- 10,160名受益人符合标准;13.3%的受益人表示不符合标准.
- 以前的不遵守强烈预测了当前的不遵守 (OR 2.65).
- 随机森林和包装模型显示了合理的预测性能 (AUC ~ 0.7),而包装模型提供了更高的灵敏度 (51%).
结论:
- 使用Medicare索赔数据的机器学习模型可以合理预测IBD中的药物不服药.
- 包装模型,由于其较低的假阴性率,是临床决策支持工具的潜在候选者,以增强坚持.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
439
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
439
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
437
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
437
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
609
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
609
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454
Inflammatory Bowel Disease II: Crohn's Disease
912
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
912
Drugs for Treatment of Ulcerative Colitis in IBD
416
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
416

